CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Celltrion Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Celltrion Inc
23, Academy-ro, Yeonsu-gu
Phone: +82 216618722p:+82 216618722 INCHEON, 22014  South Korea Ticker: 068270068270
Business Summary
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman Jeong JinSeo 66 3/28/2023 7/17/2008
President Jeong WonYoon 57 1/1/2022 1/1/2008
Co-Chief Executive Officer, Vice Chairman Wu SeongGi 62 12/28/2023 1/1/2008
12 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
CELLTRION HEALTHCARE IRELAND LIMITED SUITE 26 ARROW BUILDING OLD BELGARD ROAD TALLAGHT IE
CELLTRION HEALTHCARE UNITED KINGDOM LIMITED THE SWITCH 1-7 THE GROVE SLOUGH UK
CELLTRION HEALTHCARE BELGIUM SPRL CARREFOUR DE L'EUROPE 2 BRUXELLES BE
3 additional Subsidiary records available in full report.

Business Names
Business Name
068270
CELLTRION HEALTHCARE BELGIUM SPRL
Celltrion HealthCare Co Ltd
8 additional Business Names available in full report.

General Information
Number of Employees: 1,074 (As of 12/31/2015)
Outstanding Shares: 212,883,960 (As of 2/14/2024)
Shareholders: 535,903
Stock Exchange: KRX
Fax Number: +82 328505036


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, April 25, 2024